Medical Communications

MSD’s anti-PD-L1 therapy Keytruda (pembrolizumab) has been awarded marketing authorisation in Europe for the first-line treatment of adult patients with …

The US Department of Justice has launched an investigation into the sales and marketing practices of San Diego firm Acadia …

Ian Read has seen his total compensation cut from a sum of $27.9 million in 2018 to $19.5 million this …

Richard Francis is set to step down his role as Chief Executive of Novartis’ generics arm Sandoz after five years’ …

A California jury has ordered American healthcare conglomerate Johnson & Johnson to pay more than $29 million to a woman …

Following the surprise resignation of current FDA Commissioner Dr Scott Gottlieb a week earlier, Dr Norman ‘Ned’ Sharpless, Director of …

The healthcare industry could take up to five years to stabilise in the event of a no-deal Brexit, according to …

French company Innate Pharma have announced the appointment of Jennifer Butler to the position of Executive Vice President and General …

Louis Goss asks what the future might hold for the safety of pharmaceuticals and looks into why crucial pharmacovigilance practices …

Dr Scott Gottlieb, the 23rd Commissioner of the US Food and Drug Administration (FDA), stoked surprise throughout the industry with …

There has been a sharp increase in cases of measles across Greater Manchester, Public Health England has warned, following increasingly …

HIV hit the headlines this week after it was announced that a British man known only as the ‘London Patient’ …

A long acting, injectable two drug regimen developed by Pfizer and GSK joint venture ViiV Healthcare and J&J subsidiary Jannsen, …

Roche has announced the approval of the European Commission for its PD-L1 inhibitor Tecentriq (atezolizumab) when used in combination with …

Dutch pharmacists have vowed to circumvent rules enforcing Novartis’ market exclusivity for radioactive cancer drug Lutathera.   Pharmacists at Erasmus, …